Idorsia
Anne-Catherine Meyer has a strong background in the pharmaceutical industry. Anne-Catherine started their career at Hoffmann-La Roche in 1998 as a Global Pharma Finance Information Manager. Anne-Catherine then moved to Roche, where they held various roles including Quality Control and Galenical Manufacturing Controller and Lead of Biotech Manufacturing Controlling. In 2009, they joined Actelion as a Technical Operations Senior Controller before transitioning to Novartis as a Senior Business Planning Analyst in 2012. Anne-Catherine returned to Actelion in 2013 and served as a Senior Planning and Procurement Manager until 2017. Since 2017, Anne-Catherine has been working at Idorsia Pharmaceuticals Ltd, initially as a Director Team Leader for Planning Supply and Logistic and currently as an Associate Director for Global Product Sourcing.
Anne-Catherine Meyer attended ISG Institut Supérieur de Gestion from 1991 to 1994, although no degree or field of study information has been provided.
This person is not in any teams
Idorsia
4 followers
Idorsia Ltd is a Switzerland-based biopharmaceutical company, which specializes in the discovery and development of small molecules, to meet significant unmet medical needs. The Company will have a diverse clinical development pipeline comprising several compounds being investigated in multiple therapeutic areas, including central nervous system disorders, cardiovascular disorders, immunological disorders and orphan diseases. The Company's development compounds target a number of different diseases such as: Resistant Hypertension, Systemic lupus erythematosus, Chronic insomnia and Fabry disease, among others.